Social comments show how patients, caregivers, and HCPs interpret your content in real time. They reveal where questions keep surfacing, where misinformation starts to take hold, and how people ...

The high cost of GLP-1s is causing some employers to reconsider their coverage, a new survey from the Business Group on Health found. The survey received responses from 105 self-funded employers. It ...

Critical care transport is one of the most intense and demanding parts of emergency medical services. We’re talking about patients in the most fragile situations: premature newborns, trauma victims, ...

It’s 2 a.m. A mother calls into a nurse triage line. Her baby isn’t screaming. She’s not rattling off symptoms. She just keeps saying, “something’s wrong.” And the nurse on the other end of that phone ...

The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. Experts think the new strike force ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S.

Bayer is paying $300 million to buy Perfuse Therapeutics, a clinical-stage biotech that offers a new growth opportunity in ophthalmology as the pharmaceutical company’s top eye product weathers ...

Rosarium Health, a company enabling aging at home, has raised $6 million in seed funding and secured partnerships with several Medicaid and Medicare Advantage plans, the company shared with MedCity ...

Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California ...

April has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, Aledade, ...

Tennessee lawmakers recently passed a bill banning PBMs from owning pharmacies in the state, though like a similar Arkansas ...